AIDS Weekly
Susan Hasty, Publisher
Table of Contents . . . March 31st, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
HIV/AIDS Therapy - Antiretroviral therapy improves VH3 humoral responses
HIV/AIDS Vaccine - Recipients at risk for false positive test results
HIV/AIDS Therapy - Anti-glycoprotein 41 immunotoxins effective in mice
HIV/AIDS Therapy - Cytokine profile changes linked to effective treatment
HIV/AIDS Therapy - Nelfinavir inhibits lymphocyte P-glycoprotein activity
HIV/AIDS Vertical Transmission - Zidovudine prophylaxis has no long-term adverse effects
AIDS Therapy - Promising HIV drug completes successful clinical trial
AIDS Therapy - Trizivir inferior to two other treatments, according to NIAID clinical advisory
Antiviral Therapy - Interim data to be presented on phase IIb study in HIV/AIDS
Chlamydia - China's hidden epidemic
Diagnostics - Novel molecular conjugates aid signal amplification for immunodiagnostic assays
HIV/AIDS Dementia - Novel mechanism identified for neural cell infection
HIV/AIDS Epidemiology - Reporting requirements for HIV/AIDS reviewed
HIV/AIDS Gene Therapy - Cyclophilin A binding region blocks lentiviral vector simian cell transduction
HIV/AIDS Opportunistic Infections - Zoonotic Cryptosporidium species common in Thailand
HIV/AIDS Pathogenesis - Sphingolipid-enriched, detergent-resistant rafts not needed for cell entry
HIV/AIDS Pathogenesis - Syndecan plays key role
HIV/AIDS Proteomics - Alternative gp120 V3 loop conformations mimic chemokine beta hairpins
HIV/AIDS Proteomics - PDI-mediated reduction of gp120 disulfide bonds needed for virus/cell fusion
HIV/AIDS Public Health - New CDC guidelines on HIV counseling and testing published
HIV/AIDS Therapy - Antiretroviral treatment has limited impact on bone degradation
HIV/AIDS Therapy - Different blood cell types have varying drug resistance rates
HIV/AIDS Therapy - Regional European differences in AIDS-defining events persist
HIV/AIDS Vaccine - Salmonella secretion antigen delivery primes SIV-specific T-cell response
HIV/AIDS Vaccine - Live-attenuated SIV expressing interleukin-4 stimulate immune response
HIV/AIDS Vaccine - Molecular characteristics of HIV-1 subtype C viruses elucidated
HIV/AIDS Women's Health - C-reactive protein levels predict mortality risk
HIV/AIDS Women's Health - Low testosterone levels linked to weight loss
HIV/AIDS Women's Health - Single, poor women have higher pneumonia risk in Kenya
Healthcare Costs - New AIDS drug price spurs questions
Kaposi Sarcoma - Viral gene responsible for oncogenesis identified
Public Health - HIV coinfection uncommon in the United Kingdom
Research Funding - $1.6 million Ryan White Grant to fund information technology study
Research Funding - amfAR awards $1.2 million for new HIV/AIDS research
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
